Age group comparisons | ||||
---|---|---|---|---|
PMID | Age/Age interval, Gender | Value (unit of measurement) | Method | Sample |
18384253 | Age 24.5 ± 3, Gender ⚥ | 1.0 (mean value of the compound area) | LC-MS; GC-MS | plasma |
18384253 | Age 40.8 ± 5.6, Gender ⚥ | 0.95 (mean value of the compound area) | LC-MS; GC-MS | plasma |
18384253 | Age 55.6 ± 3.7, Gender ⚥ | 1.03 (mean value of the compound area) | LC-MS; GC-MS | plasma |
23483888 | Age 30 ± 5 , Gender ⚥ | 87.7 (ng/100 μl serum) | LC-MS/MS | serum |
23483888 | Age 70.7 ± 6, Gender ⚥ | 80.5 (ng/100 μl serum) | LC-MS/MS | serum |
23483888 | Age 100.9 ± 2, Gender ⚥ | 71.3 (ng/100 μl serum) | LC-MS/MS | serum |
12768504 | Age 32.6 ± 4.4 , Gender ♀ | 50.0 (μmol/l) | LC | blood |
12768504 | Age 48 ± 4.3, Gender ♀ | 51.0 (μmol/l) | LC | blood |
12768504 | Age 74.7 ± 10, Gender ♀ | 46.0 (μmol/l) | LC | blood |
12768504 | Age 33.3 ± 3.8, Gender ♂ | 65.0 (μmol/l) | LC | blood |
12768504 | Age 48.4 ± 6, Gender ♂ | 54.0 (μmol/l) | LC | blood |
12768504 | Age 75.9 ± 9.3, Gender ♂ | 55.0 (μmol/l) | LC | blood |
Linear regression | ||||
---|---|---|---|---|
PMID | Age/Age interval, Gender | Value (unit of measurement) | Method | Sample |
22834969 | Age 54.1 ± 13.1, Gender ♀ | -0.24 (β) | FIA-MS/MS | serum |
22834969 | Age 53.6 ± 12.5, Gender ♂ | -0.46 (β) | FIA-MS/MS | serum |
log2 ratio/log2(FC) | ||||
---|---|---|---|---|
PMID | Age/Age interval, Gender | Value (unit of measurement) | Method | Sample |
26088811 | Age 40.9 ± 10.3, Gender ⚥ | -0.91 (log2 ratio) | UHPLC negative mode | urine |